Cargando…

Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control

OBJECTIVE: This study was aimed at determining the prevalence of alexithymia in patients with type 2 DM and the factors affecting it. METHODS: This cross-sectional study was conducted with 326 patients with type 2 DM. Study data were collected with the Personal Information Form, Toronto Alexithymia...

Descripción completa

Detalles Bibliográficos
Autores principales: Avci, Dilek, Kelleci, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959761/
https://www.ncbi.nlm.nih.gov/pubmed/27499615
http://dx.doi.org/10.2147/PPA.S110903
_version_ 1782444443929935872
author Avci, Dilek
Kelleci, Meral
author_facet Avci, Dilek
Kelleci, Meral
author_sort Avci, Dilek
collection PubMed
description OBJECTIVE: This study was aimed at determining the prevalence of alexithymia in patients with type 2 DM and the factors affecting it. METHODS: This cross-sectional study was conducted with 326 patients with type 2 DM. Study data were collected with the Personal Information Form, Toronto Alexithymia Scale, and Hospital Anxiety and Depression Scale. Glycemic control was assessed by glycated haemoglobin (HbA1c) results. The analysis was performed using descriptive statistics, chi-square test, Pear-son’s correlation, and logistic regression analysis. RESULTS: Of the patients, 37.7% were determined to have alexithymia. A significant relationship was determined between alexithymia and HbA1c, depression, and anxiety. According to binary logistic regression analyses, alexithymia was 2.63 times higher among those who were in a paid employment than those who were not, 2.09 times higher among those whose HbA1c levels were ≥7.0% than those whose HbA1c levels were <7.0%, 3.77 times higher among those whose anxiety subscale scores were ≥11 than those whose anxiety subscale scores were ≤10, and 2.57 times higher among those whose depression subscale scores were ≥8 than those whose depression subscale scores were ≤7. CONCLUSION: In this study, it was determined that two out of every five patients with DM had alexithymia. Therefore, their treatment should be arranged to include mental health care services.
format Online
Article
Text
id pubmed-4959761
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49597612016-08-05 Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control Avci, Dilek Kelleci, Meral Patient Prefer Adherence Original Research OBJECTIVE: This study was aimed at determining the prevalence of alexithymia in patients with type 2 DM and the factors affecting it. METHODS: This cross-sectional study was conducted with 326 patients with type 2 DM. Study data were collected with the Personal Information Form, Toronto Alexithymia Scale, and Hospital Anxiety and Depression Scale. Glycemic control was assessed by glycated haemoglobin (HbA1c) results. The analysis was performed using descriptive statistics, chi-square test, Pear-son’s correlation, and logistic regression analysis. RESULTS: Of the patients, 37.7% were determined to have alexithymia. A significant relationship was determined between alexithymia and HbA1c, depression, and anxiety. According to binary logistic regression analyses, alexithymia was 2.63 times higher among those who were in a paid employment than those who were not, 2.09 times higher among those whose HbA1c levels were ≥7.0% than those whose HbA1c levels were <7.0%, 3.77 times higher among those whose anxiety subscale scores were ≥11 than those whose anxiety subscale scores were ≤10, and 2.57 times higher among those whose depression subscale scores were ≥8 than those whose depression subscale scores were ≤7. CONCLUSION: In this study, it was determined that two out of every five patients with DM had alexithymia. Therefore, their treatment should be arranged to include mental health care services. Dove Medical Press 2016-07-20 /pmc/articles/PMC4959761/ /pubmed/27499615 http://dx.doi.org/10.2147/PPA.S110903 Text en © 2016 Avci and Kelleci. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Avci, Dilek
Kelleci, Meral
Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title_full Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title_fullStr Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title_full_unstemmed Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title_short Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
title_sort alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959761/
https://www.ncbi.nlm.nih.gov/pubmed/27499615
http://dx.doi.org/10.2147/PPA.S110903
work_keys_str_mv AT avcidilek alexithymiainpatientswithtype2diabetesmellitustheroleofanxietydepressionandglycemiccontrol
AT kellecimeral alexithymiainpatientswithtype2diabetesmellitustheroleofanxietydepressionandglycemiccontrol